Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2018 Aug 7;72(6):702.
doi: 10.1016/j.jacc.2018.06.005.

Reply: Immunosuppression Does Not Reduce Antitumor Efficacy

Syed S Mahmood, Ryan J Sullivan, Kerry L Reynolds, Tomas G Neilan
Comment

Reply: Immunosuppression Does Not Reduce Antitumor Efficacy

Syed S Mahmood et al. J Am Coll Cardiol. .
No abstract available

PubMed Disclaimer

Comment on

  • Myocarditis in Patients Treated With Immune Checkpoint Inhibitors.
    Mahmood SS, Fradley MG, Cohen JV, Nohria A, Reynolds KL, Heinzerling LM, Sullivan RJ, Damrongwatanasuk R, Chen CL, Gupta D, Kirchberger MC, Awadalla M, Hassan MZO, Moslehi JJ, Shah SP, Ganatra S, Thavendiranathan P, Lawrence DP, Groarke JD, Neilan TG. Mahmood SS, et al. J Am Coll Cardiol. 2018 Apr 24;71(16):1755-1764. doi: 10.1016/j.jacc.2018.02.037. Epub 2018 Mar 19. J Am Coll Cardiol. 2018. PMID: 29567210 Free PMC article.
  • Immunosuppression Does Not Reduce Antitumor Efficacy.
    Cao TH. Cao TH. J Am Coll Cardiol. 2018 Aug 7;72(6):701. doi: 10.1016/j.jacc.2018.04.087. J Am Coll Cardiol. 2018. PMID: 30072006 No abstract available.

Similar articles

See all similar articles

Cited by

References

    1. Mahmood SS, Fradley MG, Cohen JV, et al. Myocarditis in patients treated with immune checkpoint inhibitors. J Am Coll Cardiol 2018;71: 1755–64. - PMC - PubMed
    1. Horvat TZ, Adel NG, Dang TO, et al. Immune-related adverse events, need for systemic immunosuppression, and effects on survival and time to treatment failure in patients with melanoma treated with ipilimumab at Memorial Sloan Kettering Cancer Center. J Clin Oncol 2015;33:3193. - PMC - PubMed
    1. Weber JS, Hodi FS, Wolchok JD, et al. Safety profile of nivolumab monotherapy: a pooled analysis of patients with advanced melanoma. J Clin Oncol 2017;35:785–92. - PubMed
    1. Ganatra S, Neilan TG. Immune checkpoint inhibitor-associated myocarditis. Oncologist 2018. May 25 [E-pub ahead of print]. - PMC - PubMed
    1. Neilan TG, Rothenberg ML, Amiri-Kordestani L, et al. Myocarditis associated with immune checkpoint inhibitors: an expert consensus on data gaps and a call to action. Oncologist 2018. May 25 [E-pub ahead of print]. - PMC - PubMed

Substances

LinkOut - more resources